PLPlanet Labs PBC
Is the business good?
The checks split: margins widening, but 2 of 9 health tests passed.
Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.
Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is PL?
Planet Labs PBC keeps −27% of every revenue dollar as operating profit, against 9.6% for the median Aerospace & Defense name.
Operating margin · Aerospace & Defense median 9.6% · 12 months to Q2 2027
- Share count, year on year
- +18%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 34%
R&D as % of revenue
- Gross margin
- 55%
Gross margin
| Year | Operating margin |
|---|---|
| FY2021 | −77% |
| FY2022 | −98% |
| FY2023 | −92% |
| FY2024 | −77% |
| FY2025 | −48% |
| FY2026 | −31% |
Details›
- Gross margin12 months to Q2 2027
- 55%
- Operating margin12 months to Q2 2027
- −27%
- Net margin12 months to Q2 2027
- −95%
- Free cash flow margin
- 6.5%
- R&D as % of revenue
- 34%
- Revenue, trailing twelve months
- $378M
- Free cash flow, trailing twelve months
- $25M
- Net income, trailing twelve months
- −$360M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Aerospace & Defense
Ranks #32 of 36 by RyuScore